Apothecary Pharma recalls

Apothecary Pharma has 2 recalls on record with the FDA and USDA, the earliest in 2026 and the latest reported on 14 Oct 2026. 2 are still ongoing. 2 were reported in the last 12 months. The most frequent reason is sterility.

Total recalls2since 2026

Last 12 months2reported

Class I00% of total

Ongoing2latest 14 Oct 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 2

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why apothecary pharma is recalled

Sterility2100%

Product types

Diabetes Medication150%
Injectable & IV Drugs150%

By year

20262100%

Ongoing apothecary pharma recalls

2 active

Reported	Class	Recall	Company	Reason	Where
14 Oct 2026Drug	CLASS II	Apothecary NAD+ Injection 200 mg/mL Sterile Multi-Dose Vial recalled	Apothecary Pharma	Sterility	Nationwide
14 Oct 2026Drug	CLASS II	Tirzepatide Injection, 18mg/mL Sterile Multi-Dose Vial recalled	Apothecary Pharma	Sterility	Nationwide

All apothecary pharma recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
14 Oct 2026Drug	CLASS II	Apothecary NAD+ Injection 200 mg/mL Sterile Multi-Dose Vial recalled	Apothecary Pharma	Sterility	Nationwide
14 Oct 2026Drug	CLASS II	Tirzepatide Injection, 18mg/mL Sterile Multi-Dose Vial recalled	Apothecary Pharma	Sterility	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.